[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350142-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350142-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","utility-of-prostate-specific-antigen-density-and-its-correlation-with-gleason-grade-groups-a-hospital-based-cross-sectional-study","Utility of Prostate-Specific Antigen Density and Its Correlation with Gleason Grade Groups - A Hospital-Based Cross-Sectional Study","","At Bugando Medical Centre, prostate cancer accounts for 39% of male oncology admissions and most cases present with high Gleason grades. A hospital-based cross-sectional study assessed whether prostate-specific antigen density (PSAD) and PSA improve risk assessment and biopsy triage among patients with prostate-related urinary symptoms. PSAD and prostate volume were measured, optimal cutoffs derived from receiver operating characteristic curves, and histopathology confirmed diagnoses. PSAD showed diagnostic value (AUC ~0.9094) and a weak positive correlation with Gleason grade groups, supporting PSAD for guiding biopsy and risk stratification.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/utility-of-prostate-specific-antigen-density-and-its-correlation-with-gleason-grade-groups-a-hospital-based-cross-sectional-study/350142/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/utility-of-prostate-specific-antigen-density-and-its-correlation-with-gleason-grade-groups-a-hospital-based-cross-sectional-study/350142.png","ImageObject",300,407,{"name":42,"@type":43},"Jordan Avery","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary goal of the study?","Question",{"text":63,"@type":64},"To determine the utility of prostate-specific antigen density (PSAD) for detecting prostate cancer and to establish a PSAD cutoff that supports biopsy decision-making in patients with LUTS at Bugando Medical Centre.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PSAD evaluated in the study?",{"text":68,"@type":64},"PSAD was calculated using total serum PSA and measured prostate volume. The optimal cutoff was selected using the receiver operating characteristic (ROC) curve.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship did the study find between PSAD and Gleason grade groups?",{"text":72,"@type":64},"A weak positive correlation was observed between PSAD and Gleason grade groups (Spearman’s rho ρ = 0.2456), indicating that higher PSAD was associated with more aggressive disease.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350142,1790118960,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":112,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Jackson et al. BMC Urology (2026) 26:101 [https://doi.org/10.1186/s12894-026-02101-9](https://doi.org/10.1186/s12894-026-02101-9)  \nBMC Urology  \nRESEARCH Open Access  \nUtility of prostate-specific antigen density and its correlation with Gleason grade groups: a hospital-based cross-sectional study among patients with prostate-related urinary symptoms at Bugando Medical Centre, Mwanza, Tanzania  \nNgutunyi Jackson1, Edrick Elias2*, John Igenge3, Oscar Ottoman2, Subira Matiku2, Shaban Idd2, Alex Mremi4, Cosmas Mbulwa2, Jackson Kahima2, Benson Kidenya5 and Peter Rambau2  \nAbstract  \nBackground At Bugando Medical Centre, prostate cancer contributes to 39% of all cancers in male patients admitted to the Oncology department, and the majority have high Gleason grades. Although Prostate-specific antigen density (PSAD) has been shown to improve the diagnostic accuracy of prostate cancer and to triage patients for prostate biopsy, there is a significant variation across geographical locations.  \nMethods A hospital-based cross-sectional study among patients with prostate-related urinary symptoms at Bugando Medical Centre, Mwanza, Tanzania. The study analyzed prostate-specific antigen levels, prostate volume, and total PSA using Maglumi 2000 and a computer system. Histopathological examination involved transrectal biopsy, TURP, and open prostatectomy. The optimal cutoff for PSA density was determined using the receiver operating characteristic curve.  \nResults Of the 287 patients, the overall mean age of 71.2 (± 10 . 2) years. 99 (34 . 5%) participants were diagnosed with prostate cancer. The area under the curve for prostate-specific antigen density and PSA was 0.9094 (0 .8761–0. 9426) and 0.8932 (0 .8569–0. 9295), respectively. The PSAD optimal cut-off was 0 . 23ng/ml2, giving sensitivity of 86 . 9% and specificity of 82 .4% for prostate cancer prediction. Using this cutoff reduces prostate biopsies by 54. 5% . There was a weak positive correlation (Spearman’s rho (ρ) = 0 . 2456) between prostate-specific antigen density and Gleason grade groups.  \n*Correspondence:  \nEdrick Elias [mtalemwae@gmail.com](mtalemwae@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nJackson et al. BMC Urology (2026) 26:101 Page 2 of 8  \nConclusions The correlation between PSAD and Gleason grade groups observed in this study suggests that higher PSAD is associated with more aggressive cancer. This makes PSAD a valuable tool in guiding biopsy decisions, risk stratification, and treatment planning in patients with prostate-related urinary symptoms.  \nKeywords Cut-off value, Gleason score, Prostate cancer, Prostate-specific antigen density  \nBackground  \nProstate cancer is the second most common cancer in men worldwide and is estimated to have almost 1.4 million new cases yearly and cause 375,000 deaths ","cbCaiguTfLRsiUAk","https://ap.wps.com/l/cbCaiguTfLRsiUAk","pdf",1463700,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n# Methods","[{\"question\":\"What was the primary goal of the study?\",\"answer\":\"To determine the utility of prostate-specific antigen density (PSAD) for detecting prostate cancer and to establish a PSAD cutoff that supports biopsy decision-making in patients with LUTS at Bugando Medical Centre.\"},{\"question\":\"How was PSAD evaluated in the study?\",\"answer\":\"PSAD was calculated using total serum PSA and measured prostate volume. The optimal cutoff was selected using the receiver operating characteristic (ROC) curve.\"},{\"question\":\"What relationship did the study find between PSAD and Gleason grade groups?\",\"answer\":\"A weak positive correlation was observed between PSAD and Gleason grade groups (Spearman’s rho ρ = 0.2456), indicating that higher PSAD was associated with more aggressive disease.\"}]","Utility of Prostate-Specific Antigen Density and Its Correlation with Gleason Grade Groups - A Hospital-Based Cross-Sectional Study | PDF",1790087362,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f1ae0aed93bc469cc1f72b4687eb998.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46735f0bcb20d8596c3e9b6284b2266e.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2948840ef28163e83f9e9c9f82d5e9cf.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50fe03460c22f05d88efff3721398779.webp",980,1306]